| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |